Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 2,058,112 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Omada Health had revenue of $189.67 million and -$37.62 million in losses. Loss per share was -$4.76.
Revenue | 189.67M |
Gross Profit | 117.43M |
Operating Income | -34.06M |
Pretax Income | -37.62M |
Net Income | -37.62M |
EBITDA | -29.05M |
EBIT | -34.06M |
Loss Per Share | -$4.76 |
Full Income Statement Balance Sheet
The company has $59.40 million in cash and $30.08 million in debt, giving a net cash position of $29.32 million or $0.52 per share.
Cash & Cash Equivalents | 59.40M |
Total Debt | 30.08M |
Net Cash | 29.32M |
Net Cash Per Share | $0.52 |
Equity (Book Value) | 58.99M |
Book Value Per Share | -46.65 |
Working Capital | 53.33M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$29.65 million and capital expenditures -$727,000, giving a free cash flow of -$30.38 million.
Operating Cash Flow | -29.65M |
Capital Expenditures | -727,000 |
Free Cash Flow | -30.38M |
FCF Per Share | -$0.53 |
Full Cash Flow Statement Margins
Gross margin is 61.91%, with operating and profit margins of -17.96% and -19.83%.
Gross Margin | 61.91% |
Operating Margin | -17.96% |
Pretax Margin | -19.83% |
Profit Margin | -19.83% |
EBITDA Margin | -15.31% |
EBIT Margin | -17.96% |
FCF Margin | n/a |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.77% |
FCF Yield | -3.04% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of -3.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.5 |
Piotroski F-Score | 1 |